Explore the neuroprotective effects of LY2405319, an engineered FGF21 analogue with potential for treating Alzheimer's disease through multiple mechanisms.
Discover groundbreaking insights from the 2017 Barshop Symposium on aging research, including sex differences in aging, stroke recovery genetics, and Alzheimer's mechanisms.